Publish Date: 
Thursday, November 2, 2017 - 17:00

UniQuest collaborates with MSD to develop immuno-oncology therapies

Global health care leader MSD has signed an agreement with The University of Queensland to develop a platform for new immuno-oncology therapies.

The collaboration will combine the expertise of MSD's Research Labs in oncology and immunotherapy with the work of Professor Ranjeny Thomas and Professor Riccardo Dolcetti at UQ’s Diamantina Institute to developing new treatments for cancer.

Professor Thomas said the agreement, signed with UQ commercialisation company UniQuest Pty Ltd, was an exciting collaboration.

> Click to read the full article

Media: Uniquest, Danielle Koopman, +61 409 767 199; MSD, Tanya Holloway, +61 407 695 885

Summary: 
Global health care leader MSD has signed an agreement with The University of Queensland to develop a platform for new immuno-oncology therapies.